Racial/ethnic disparities in exposure to COVID-19, susceptibility to COVID-19 and access to health care – findings from a U.S. national cohort

INTRODUCTION

Researchers have identified underlying medical conditions, comorbidities, older age, and male sex as biological vulnerabilities for more severe Coronavirus Disease 2019 (COVID-19) outcomes.(1,2) Evidence also suggests a disproportionate burden of COVID-19 infection, hospitalization, and death among Hispanic and Black Non Hispanic (NH) individuals in the United States (U.S.).(3–6) Early in the pandemic (March 2020) the Centers for Disease Control and Prevention (CDC) reported that twice as many Black individuals were hospitalized with COVID-19 than are proportionally represented in the U.S.(3) Long-standing health and social inequities likely contribute to disparities in COVID-19 morbidity and mortality.(7–9)

Public health interventions and policies with the potential to improve health may inadvertently amplify existing health disparities.(7) Prevention efforts, such as social distancing or work from home policies, may not benefit racial and ethnic minority groups as much as non-minority and more advantaged groups, given they are disproportionately represented in essential work settings and/or more likely to live in multi-generational households.(7,8,10) Less access to and utilization of healthcare also result in worse COVID-19 outcomes among racial and ethnic minority groups since later care presentation provides less opportunity to benefit from various treatment modalities.(8,11) Barriers to healthcare access may also increase the likelihood of staying at home longer while infectious. Blumenshine et al., proposed a pandemic disease model in which differences in socioeconomic position (SEP) contribute to disparities in exposure, susceptibility to illness, if exposed, and access to treatment before disease development.(12) In the Blumenshine model, disparities in exposure, susceptibility, and access may lead to unequal levels of infection, morbidity and mortality during a pandemic. To avoid exacerbating existing disparities, effective public health interventions and pandemic guidelines need to anticipate and mitigate the contribution of SEP to racial/ethnic disparities.(9,12,13)

Our objective was to examine the influence of racial and ethnic differences in SEP on COVID-19 outcomes within a large U.S. national cohort that was enrolled during the spring of 2020, the early phase of the COVID-19 pandemic. Using the Blumenshine model as a framework, we created three indices to assess SEP: a) the ability to social distance as a measure of exposure to COVID-19, b) susceptibility to COVID-19 complications, and c) access to healthcare. We examined the relationship between each SEP index with COVID-19 outcomes (COVID-19 hospitalization or seroconversion), and we assessed race/ethnicity as a potential effect measure modifier (EMM) of the relationship between each SEP index and COVID-19 outcome.

METHODS

RESULTS

This analysis utilized data from 6,740 individuals enrolled into prospective follow-up for analyses assessing the hospitalization outcome reported through October 20, 2021. Among the full cohort 19% (N=1,308) identified as Hispanic ethnicity, 13% (N=899) as Black NH, 7% (N=465) as API NH, 57% (N=3,846) as White NH, and 3% (N=222) as other NH race (Table 1). Hispanics, Black NH, or API NH were younger on average than White NH (mean age in years [Standard Deviation]: 35 [13], 35 [13], 33 [12] versus 45 [16], respectively). More than half of the cohort was women (52%). Over half of the cohort (57%) had a college-level education, and the proportion with a college-education was highest among API NH (69%) and lowest among Black NH participants (33%).

For seroconversion analyses, we used a subset of 3,422 participants seronegative in May-September 2020 and testing during November 2020-January 2021 (subset of testers). Compared to the full cohort, the subset of testers had more White NH participants (57% versus 67%), was older (mean: 44 years versus 41 years) and had higher educational attainment (57% versus 67% with at least a college education) (Supplemental Table 1).

DISCUSSION

Our study confirms the existence of significant racial and ethnic differences in potential COVID-19 exposure risk, susceptibility to COVID-19 complications, and access to health care within a large U.S. national cohort. The proportion with more exposure risk and more difficulty with healthcare access was significantly higher among Black NH, Hispanic and API NH than White NH participants. More exposure, as measured by reduced ability to social distance, increased the odds of seroconversion by 64% and hospitalization by 73%. More underlying susceptibility and more difficulty with access to care increased the odds of hospitalization by 113-136%.

Many have hypothesized that SEP influences the differential impact of the COVID-19 pandemic either directly or indirectly via occupation, living and working conditions, health-related behaviors, presence of comorbidities and immune functioning.(8,11,12) However, the influence of SEP on COVID-19 transmission, severity and outcomes is understudied, and existing research has largely characterized SEP using geography and race/ethnicity as a proxies.(21–27) For example, U.S. counties with a higher proportion of Black or Hispanic population or of adults with less than a high school diploma had disproportionately higher COVID-19 cases.(26) Using data from the American Community Survey to characterize socioeconomic vulnerability at the neighborhood level, ecologic analyses have demonstrated that increasing levels of socioeconomic vulnerability were associated with gaps in COVID-19 testing coverage in Massachusetts and COVID-19 mortality in Chicago.(21,27) Although useful, such approaches may mask the extent of inequity and the influence of SEP at the individual-level. We are aware of one study that included individual-level social indicators to assess COVD-19 outcomes.(28) Hispanic ethnicity, inability to shelter in place and maintain income, frontline service work, unemployment, and household income <$50,000 increased the risk of COVID-19 infection among residents and workers located in small community within San Francisco.(28) We provide empirical evidence to support the conceptual model of Blumenshine, et al, in the context of the COVID-19 pandemic.(12) Differences in SEP contribute to disparities in exposure, susceptibility to illness given infection, and timely access to care and supportive treatment. Further, reduced ability to social distance was positively associated with seroconversion and hospitalization, and increased susceptibility to COVID-19 complications and poor access to healthcare were positively associated with hospitalization. We did not observe an association between seroconversion with susceptibility or access to care. The null finding is unsurprising given susceptibility to complications and access to care would be expected to influence illness following infection. Primary and secondary prevention efforts should address potential social disparities in exposure, COVID-19 vaccination, and access to care/treatment.

Our finding that Hispanic and Black NH participants had more exposure and more difficulty with healthcare access than White NH participants is consistent with other research showing a disproportionate burden of COVID-19 infections, complications and mortality on racial and ethnic minorities.(3,5,8,23,29–35) The positive additive interaction observed between racial and ethnic minority group status and susceptibility to severe COVID-19 disease with hospitalization is especially concerning. We did not observe evidence of EMM by race/ethnicity in terms of the COVID exposure index or the healthcare access index. The implication of these findings is that non-White populations should be prioritized in efforts to reduce susceptibility, whereas interventions to reduce COVID exposure (i.e., social distancing ability) and healthcare access should target everyone. Recommendations for and discussions about social distancing fail to account for the reality of differential ability to adopt and benefit from these approaches, creating inequities in health outcomes. Long-standing health disparities contribute to susceptibility among Hispanic and Black NH individuals and susceptibility is also influenced by lower healthcare access. Mitigation strategies and messaging should intensify focus on Hispanic and Black NH individuals with conditions that increase risk of COVID-19 morbidity and mortality and incorporate targeted, culturally appropriate communication.

As with all observational studies, confounding of the exposure-outcome relationship is a concern, and we did not address the possibility of joint effects of the SEP indices. All exposure data was collected at cohort enrollment. The benefit of using enrollment data for exposure measurement is that all participants had to complete the screening tool to enroll into prospective follow-up. Thus, missing data was minimized. Measurement error may be a concern given data on hospitalizations was self-reported.

There have been increasing calls for research to better capture and report on socioeconomic determinants of COVID-19 outcomes alongside race/ethnicity to identify populations that may experience a disproportionate burden of risk and/or ability to benefit from pandemic mitigation strategies.(10,13) We observed significant racial/ethnic disparities in ability to social distance as a measure of COVID exposure, susceptibility to COVID-19 complications and access to healthcare in our national cohort. To the best of our knowledge, we present some of the first data, measured at the individual level, to demonstrate racial/ethnic differences in these factors and their association with seroconversion and hospitalization. Future pandemic mitigation strategies should account for the inequities in burden that can be introduced via SEP in relation to pathogen exposure, susceptibility, and health care access.

CONTRIBUTORS

MMR and DN conceptualized the study. MMR and MS performed statistical analyses. MMR and MS wrote the first draft of the paper. MMR, EB, DN, and MS contributed to interpreting the data. MMR, MS, EB, DN, MM, MR DAW, AMP, RZ, ARM, SGK, and CG contributed to the writing and revising of the manuscript. MR, MMR, SGK and DN contributed to data collection, cleaning and management. DN, SGK, MMR and CG contributed to obtaining funding for the research.

FUNDING

Funding for this project is provided by The National Institute of Allergy and Infectious Diseases (NIAID), award number 3UH3AI133675-04S1 (MPIs: D Nash and C Grov), the CUNY Institute for Implementation Science in Population Health (cunyisph.org) and the COVID-19 Grant Program of the CUNY Graduate School of Public Health and Health Policy, and National Institute of Child Health and Human Development grant P2C HD050924 (Carolina Population Center). The NIH played no role in the production of this manuscript nor necessarily endorses the findings.